{
    "nctId": "NCT01997112",
    "officialTitle": "PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study",
    "inclusionCriteria": "* \u226518 years old, men or post-menopausal women (women with no periods for 12 months or more, or those who have had a surgical menopause)\n* Treated hypertensive patients with an average daytime ambulatory blood pressure measurement (ABPM) \\<150/95mmHg on stable doses of one or more antihypertensive medication (at least one of which should be; an ACE inhibitor, angiotensin receptor blocker or diuretic) for 3 months, or untreated hypertensive patients with an average daytime ABPM \u2265135/85 but \\<150/95.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* History of ischaemic heart disease, cardiac failure, cerebrovascular disease, liver impairment (ALT/AST\\>50IU/L) or stage 3-5 chronic kidney disease.\n* History of overdose or suicidal ideation\n* Patients weighing \\<55kgs.\n* Patients with chronic pain requiring treatment, with a known allergy to paracetamol, or concomitant use of non-steroidal anti-inflammatories , oral anticoagulants or corticosteroids."
}